ITTO20050708A1 - Fluridone come agente anti-infiammatorio - Google Patents

Fluridone come agente anti-infiammatorio

Info

Publication number
ITTO20050708A1
ITTO20050708A1 IT000708A ITTO20050708A ITTO20050708A1 IT TO20050708 A1 ITTO20050708 A1 IT TO20050708A1 IT 000708 A IT000708 A IT 000708A IT TO20050708 A ITTO20050708 A IT TO20050708A IT TO20050708 A1 ITTO20050708 A1 IT TO20050708A1
Authority
IT
Italy
Prior art keywords
fluridone
inflammatory agent
inflammatory
agent
Prior art date
Application number
IT000708A
Other languages
English (en)
Inventor
Giovanna Basile
Umberto Benatti
Santina Bruzzone
Flora Antonio De
Luisa Franco
Lucrezia Guida
Mirko Magnone
Iliana Moreschi
Annalisa Salis
Sonia Scarfi
Elena Zocchi
Original Assignee
Univ Degli Studi Genova
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Degli Studi Genova filed Critical Univ Degli Studi Genova
Priority to IT000708A priority Critical patent/ITTO20050708A1/it
Priority to EP06821174A priority patent/EP1948174B1/en
Priority to US12/089,203 priority patent/US7786042B2/en
Priority to PCT/IB2006/053669 priority patent/WO2007042983A2/en
Publication of ITTO20050708A1 publication Critical patent/ITTO20050708A1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4412—Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/68—One oxygen atom attached in position 4

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IT000708A 2005-10-07 2005-10-07 Fluridone come agente anti-infiammatorio ITTO20050708A1 (it)

Priority Applications (4)

Application Number Priority Date Filing Date Title
IT000708A ITTO20050708A1 (it) 2005-10-07 2005-10-07 Fluridone come agente anti-infiammatorio
EP06821174A EP1948174B1 (en) 2005-10-07 2006-10-06 Fluridone as an anti-inflammatory agent
US12/089,203 US7786042B2 (en) 2005-10-07 2006-10-06 Fluridone as an anti-inflammatory agent
PCT/IB2006/053669 WO2007042983A2 (en) 2005-10-07 2006-10-06 Fluridone as an anti-inflammatory agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT000708A ITTO20050708A1 (it) 2005-10-07 2005-10-07 Fluridone come agente anti-infiammatorio

Publications (1)

Publication Number Publication Date
ITTO20050708A1 true ITTO20050708A1 (it) 2007-04-08

Family

ID=37882171

Family Applications (1)

Application Number Title Priority Date Filing Date
IT000708A ITTO20050708A1 (it) 2005-10-07 2005-10-07 Fluridone come agente anti-infiammatorio

Country Status (4)

Country Link
US (1) US7786042B2 (it)
EP (1) EP1948174B1 (it)
IT (1) ITTO20050708A1 (it)
WO (1) WO2007042983A2 (it)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8389024B2 (en) * 2005-06-22 2013-03-05 Gonzalo Romero M. Abscisic acid against cancer
RU2361587C1 (ru) * 2008-02-14 2009-07-20 Михаил Владимирович Кутушов Лекарственное средство для лечения онкологических заболеваний
US20100204188A1 (en) * 2009-01-28 2010-08-12 Virginia Tech Intellectual Properties, Inc. Method of synergistically enhancing the therapeutic efficacy and safety of medications through a combination therapy
CN105878224A (zh) 2010-09-17 2016-08-24 美商华仑生物科学公司 用于动物健康的脱落酸的组合物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3958025A (en) * 1972-10-06 1976-05-18 Livingston Virginia W C Abscisic acid tablets and process
GB8607749D0 (en) * 1986-03-27 1986-04-30 Hetherington A M Compounds & pharmaceutical preparations
US5859028A (en) * 1997-04-28 1999-01-12 Potomax Limited Partnership Carotenoid synthesis inhibiting herbicides and fatty acid synthesis inhibiting oxime herbicides as anti-Apicomplexa protozoan parasite agents
US6329429B1 (en) * 1997-06-25 2001-12-11 Warner-Lambert Company Use of GABA analogs such as Gabapentin in the manufacture of a medicament for treating inflammatory diseases
US20040117125A1 (en) * 1999-04-26 2004-06-17 Hao Chen Drug discovery method and apparatus

Also Published As

Publication number Publication date
US7786042B2 (en) 2010-08-31
US20080242705A1 (en) 2008-10-02
WO2007042983A2 (en) 2007-04-19
EP1948174B1 (en) 2012-08-01
WO2007042983A3 (en) 2007-07-26
EP1948174A2 (en) 2008-07-30

Similar Documents

Publication Publication Date Title
FR22C1008I2 (fr) Composition immunogène
EP1857091A4 (en) COSMETIC
EP1923431A4 (en) Curable composition
EP1967540A4 (en) HARDENING COMPOSITION
RU2398586C3 (ru) Фармацевтическая композиция
NO20055686D0 (no) Sammensetning
BRPI0716118A2 (pt) agente anti-ruga
EP1882713A4 (en) HARDENING COMPOSITION
DE602005008726D1 (de) Verwendet
EP1719409A4 (en) INSECTICIDE COMPOSITION
EP1930376A4 (en) HARDENING COMPOSITION
FR2885520B1 (fr) Composition cosmetique
DK1868586T3 (da) Antiinflammatorisk formulering
DE602006013094D1 (de) Krebsmittel
EP2111484A4 (en) POLYAMINE BRILLIANCE AGENT
EP1970411A4 (en) HARDENING COMPOSITION
DE602006000877D1 (de) Emulsionszusammensetzung
DE602006010127D1 (de) Härtbare Zusammensetzung
FI20041057L (fi) Pelkistysainekoostumus
EP1852499A4 (en) NEUROTISATIONSFÖRDERNDES AGENS
FR2871686B1 (fr) Composition anti-decoloration
FR2885521B1 (fr) Composition cosmetique
BRPI0614413A2 (pt) composto, e, composição farmacêutica
EP1894576A4 (en) NEW TRIGLYCERIDE REDUCER
BRPI0614412A2 (pt) composto, e, composição farmacêutica